BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24812288)

  • 1. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.
    Altorok N; Tsou PS; Coit P; Khanna D; Sawalha AH
    Ann Rheum Dis; 2015 Aug; 74(8):1612-20. PubMed ID: 24812288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
    Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
    Crilly A; Hamilton J; Clark CJ; Jardine A; Madhok R
    Rheumatology (Oxford); 2003 Nov; 42(11):1295-8. PubMed ID: 12867583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
    Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
    Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation pattern in systemic sclerosis microvascular endothelial cells: Identification of epigenetically affected key genes and pathways.
    Nada S; Kahaleh B; Altorok N
    J Scleroderma Relat Disord; 2022 Feb; 7(1):71-81. PubMed ID: 35386944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subsets in the gene expression signatures of scleroderma skin.
    Milano A; Pendergrass SA; Sargent JL; George LK; McCalmont TH; Connolly MK; Whitfield ML
    PLoS One; 2008 Jul; 3(7):e2696. PubMed ID: 18648520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.
    Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM
    Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of tissue kallikrein in the skin of systemic sclerosis.
    Milia AF; Del Rosso A; Pacini A; Manetti M; Marrelli A; Nosi D; Giacomelli R; Matucci-Cerinic M; Ibba-Manneschi L
    Histol Histopathol; 2005 Apr; 20(2):415-22. PubMed ID: 15736045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.
    Altorok N; Coit P; Hughes T; Koelsch KA; Stone DU; Rasmussen A; Radfar L; Scofield RH; Sivils KL; Farris AD; Sawalha AH
    Arthritis Rheumatol; 2014 Mar; 66(3):731-9. PubMed ID: 24574234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.
    Sargent JL; Milano A; Bhattacharyya S; Varga J; Connolly MK; Chang HY; Whitfield ML
    J Invest Dermatol; 2010 Mar; 130(3):694-705. PubMed ID: 19812599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
    Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
    Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
    J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study.
    Juhl P; Vinderslev Iversen L; Karlsmark T; Asser Karsdal M; Bay-Jensen AC; Mogensen M; Siebuhr AS
    Biomarkers; 2019 Jun; 24(4):373-378. PubMed ID: 30821519
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.
    Kudo H; Jinnin M; Asano Y; Trojanowska M; Nakayama W; Inoue K; Honda N; Kajihara I; Makino K; Fukushima S; Ihn H
    Arthritis Rheumatol; 2014 Jun; 66(6):1636-47. PubMed ID: 24470401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis.
    Rezaei R; Mahmoudi M; Gharibdoost F; Kavosi H; Dashti N; Imeni V; Jamshidi A; Aslani S; Mostafaei S; Vodjgani M
    Int J Rheum Dis; 2017 Oct; 20(10):1551-1561. PubMed ID: 28952189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus.
    Jeffries MA; Dozmorov M; Tang Y; Merrill JT; Wren JD; Sawalha AH
    Epigenetics; 2011 May; 6(5):593-601. PubMed ID: 21436623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis.
    Khan L; Derksen T; Redmond D; Storek J; Durand C; Gniadecki R; Korman B; Cohen Tervaert JW; D'Aubeterre A; Osman MS; Willis LM
    J Autoimmun; 2023 Nov; 140():103110. PubMed ID: 37742510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen specificity of antihistone antibodies in systemic sclerosis.
    Hasegawa M; Sato S; Kikuchi K; Takehara K
    Ann Rheum Dis; 1998 Aug; 57(8):470-5. PubMed ID: 9797552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.
    Magro CM; Nuovo G; Ferri C; Crowson AN; Giuggioli D; Sebastiani M
    J Cutan Pathol; 2004 Jan; 31(1):43-50. PubMed ID: 14675284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasminogen activator system in fibroblasts from systemic sclerosis.
    Postiglione L; Montuori N; Riccio A; Di Spigna G; Salzano S; Rossi G; Ragno P
    Int J Immunopathol Pharmacol; 2010; 23(3):891-900. PubMed ID: 20943061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.